Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression nature.com/articles/s4146…

Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesis biorxiv.org/content/10.110…

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling nature.com/articles/s4301…

Axonal injury is a targetable driver of glioblastoma progression nature.com/articles/s4158…

Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial nature.com/articles/s4159…

Long-range cholinergic input promotes glioblastoma progression cell.com/cancer-cell/ab…

Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma Therapy biorxiv.org/content/10.110…

The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis thelancet.com/journals/lanon…

Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival doi.org/10.1016/j.celr…

Nanopore sequencing of intact aminoacylated tRNAs nature.com/articles/s4146…

Extrachromosomal DNA–Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma aacrjournals.org/cancerdiscover…

Rewiring of cortical glucose metabolism fuels human brain cancer growth nature.com/articles/s4158…

MIF-induced CD74+ microglia/macrophages are clinically relevant disease-associated subpopulations in brain metastasis and other CNS disorders biorxiv.org/content/10.110…

Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape nature.com/articles/s4159…

Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma Patients medrxiv.org/content/10.110…

New online! Glioblastomas divert glucose to promote growth bit.ly/3VV2faq

TET CpG sequence context specific DNA demeth-ylation shapes progression of IDH-mutant gliomas biorxiv.org/content/10.110…

Integrated genomic and transcriptomic profiling of glioblastoma reveals ecDNA-driven heterogeneity and microenvironmental reprogramming dlvr.it/TNffFJ

Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence nature.com/articles/s4155…

ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma biorxiv.org/content/10.110…